Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Flexion enrols first subject in Phase III trial of zilretta

X-ray of hips showing narrowing of joint space, osteophyte production and increased density of bone end. Credit: Wellcome Photo Library. Wellcome Images.

  • Flexion Therapeutics

Go Top